CN103598353B - Breast base lactose-free baby formula powder - Google Patents
Breast base lactose-free baby formula powder Download PDFInfo
- Publication number
- CN103598353B CN103598353B CN201310547120.9A CN201310547120A CN103598353B CN 103598353 B CN103598353 B CN 103598353B CN 201310547120 A CN201310547120 A CN 201310547120A CN 103598353 B CN103598353 B CN 103598353B
- Authority
- CN
- China
- Prior art keywords
- vitamin
- lactose
- baby formula
- oil
- formula powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims abstract description 33
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 26
- 210000000481 breast Anatomy 0.000 title description 2
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 10
- 239000011707 mineral Substances 0.000 claims abstract description 10
- 229940088594 vitamin Drugs 0.000 claims abstract description 10
- 229930003231 vitamin Natural products 0.000 claims abstract description 10
- 235000013343 vitamin Nutrition 0.000 claims abstract description 10
- 239000011782 vitamin Substances 0.000 claims abstract description 10
- 240000008042 Zea mays Species 0.000 claims abstract description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 9
- 235000005822 corn Nutrition 0.000 claims abstract description 9
- 239000006188 syrup Substances 0.000 claims abstract description 9
- 235000020357 syrup Nutrition 0.000 claims abstract description 9
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 9
- 239000003240 coconut oil Substances 0.000 claims abstract description 8
- 235000019864 coconut oil Nutrition 0.000 claims abstract description 8
- 235000019482 Palm oil Nutrition 0.000 claims abstract description 7
- 235000019486 Sunflower oil Nutrition 0.000 claims abstract description 7
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 7
- 239000002540 palm oil Substances 0.000 claims abstract description 7
- 239000003549 soybean oil Substances 0.000 claims abstract description 7
- 235000012424 soybean oil Nutrition 0.000 claims abstract description 7
- 239000002600 sunflower oil Substances 0.000 claims abstract description 7
- 239000005862 Whey Substances 0.000 claims abstract description 6
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 6
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 6
- 235000013312 flour Nutrition 0.000 claims abstract description 6
- 239000002773 nucleotide Substances 0.000 claims abstract description 6
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims abstract description 3
- 235000019743 Choline chloride Nutrition 0.000 claims abstract description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims abstract description 3
- 229960003178 choline chloride Drugs 0.000 claims abstract description 3
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims abstract description 3
- 229940095064 tartrate Drugs 0.000 claims abstract description 3
- 229960003080 taurine Drugs 0.000 claims abstract description 3
- 235000010755 mineral Nutrition 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000002351 wastewater Substances 0.000 claims description 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 claims description 2
- 102100037966 Importin-8 Human genes 0.000 claims description 2
- 101710125767 Importin-8 Proteins 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
- 229930003451 Vitamin B1 Natural products 0.000 claims description 2
- 229930003779 Vitamin B12 Natural products 0.000 claims description 2
- 229930003471 Vitamin B2 Natural products 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 2
- 229960002079 calcium pantothenate Drugs 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 2
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 claims description 2
- 239000011790 ferrous sulphate Substances 0.000 claims description 2
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 229940099596 manganese sulfate Drugs 0.000 claims description 2
- 239000011702 manganese sulphate Substances 0.000 claims description 2
- 235000007079 manganese sulphate Nutrition 0.000 claims description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 2
- 235000019175 phylloquinone Nutrition 0.000 claims description 2
- 239000011772 phylloquinone Substances 0.000 claims description 2
- 229960001898 phytomenadione Drugs 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 239000001230 potassium iodate Substances 0.000 claims description 2
- 235000006666 potassium iodate Nutrition 0.000 claims description 2
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 claims description 2
- 229940093930 potassium iodate Drugs 0.000 claims description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 239000011781 sodium selenite Substances 0.000 claims description 2
- 235000015921 sodium selenite Nutrition 0.000 claims description 2
- 229960001471 sodium selenite Drugs 0.000 claims description 2
- 150000003538 tetroses Chemical class 0.000 claims description 2
- 229960003495 thiamine Drugs 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 235000019163 vitamin B12 Nutrition 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 235000019164 vitamin B2 Nutrition 0.000 claims description 2
- 239000011716 vitamin B2 Substances 0.000 claims description 2
- 235000019158 vitamin B6 Nutrition 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- RMDJVOZETBHEAR-LQYWTLTGSA-N vitamin D5 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CC[C@@H](CC)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C RMDJVOZETBHEAR-LQYWTLTGSA-N 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 229940045997 vitamin a Drugs 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- 239000011576 zinc lactate Substances 0.000 claims description 2
- 235000000193 zinc lactate Nutrition 0.000 claims description 2
- 229940050168 zinc lactate Drugs 0.000 claims description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 claims description 2
- 201000010538 Lactose Intolerance Diseases 0.000 abstract description 9
- 235000020190 lactose-free milk Nutrition 0.000 abstract description 4
- 102000014171 Milk Proteins Human genes 0.000 abstract description 3
- 108010011756 Milk Proteins Proteins 0.000 abstract description 3
- 235000020247 cow milk Nutrition 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 208000034657 Convalescence Diseases 0.000 abstract description 2
- 235000013365 dairy product Nutrition 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 description 14
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000019637 Infantile Diarrhea Diseases 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 235000005687 corn oil Nutrition 0.000 description 3
- 239000002285 corn oil Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 150000004667 medium chain fatty acids Chemical class 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- 108010059881 Lactase Proteins 0.000 description 2
- 241000702670 Rotavirus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000007580 dry-mixing Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 229940116108 lactase Drugs 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023648 Lactase deficiency Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 201000009840 acute diarrhea Diseases 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000023011 digestive tract development Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 201000009868 osmotic diarrhea Diseases 0.000 description 1
- 208000028719 osmotic diarrheal disease Diseases 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 235000020610 powder formula Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Dairy Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a kind of newborn base lactose-free baby formula powder and preparation method, belong to technical field of dairy processing.This newborn base lactose-free baby formula powder, is made up of the raw material of following weight ratio: casoid flour 45-50, whey isolate protein powder 95-100; corn syrup 700-750, palm oil 90-98, soybean oil 65-70; high oleic sunflower oil 55-60; coconut oil 40-50, Choline Chloride 0.7, vitamin 1.76791; mineral matter 41.5325; nucleotides 0.42, VBT tartrate 0.12, taurine 0.4.The present invention for primary raw material, makes lactose-free milk powder substitute products with cow's milk protein isolate, as the food of lactose intolerance, diarrhoea and diarrhoea convalescence special infant, simultaneously for market provides a kind of supplementary infant formula Model of Nutrition.
Description
Technical field
The present invention relates to a kind of newborn base lactose-free baby formula powder and preparation method, belong to technical field of dairy processing.
Background technology
Infantile diarrhea, have another name called infantile dyspepsia, a kind of acute gastrointestinal dysfunction of infantile period. in China, baby diarrhea occupies deputy children's's common frdquently encountered disease, especially enters autumn. infant's diarrhoea in autumn can be divided into infectious and non-infectious two classes by its cause of disease.The former mostly is virus, bacterium, fungi, parasitic infection are relevant; The latter is many to be caused by dietary factor and climatic factor. and current, the diarrhoeal diseases because of bacteriological infection is existing to be reduced, and the diarrhoea caused by virus just seems particularly outstanding, wherein typical with the infant's diarrhoea in autumn caused by rotavirus.Clinically be mainly in season early winter in late autumn, anxious with onset, state of an illness weight, heating, upper airway symptoms weight, vomiting is many, and frequently, just, the constitutional symptoms such as normal companion's dehydration acid poisoning are its feature to diarrhoea for row's rice washing water sample or egg soup sample water.Cause the main cause of infant's diarrhoea in autumn to be that infant's gut development is immature, over-burden for enteron aisle, and immune system is poor. and infant's diarrhoea in autumn is without specificity therapeutic method at present. and there are some researches show, rotavirus more than 90% is with lactose intolerance.
Clinically to the infant of acute diarrhea, while treatment protopathy, correct diet is selected to be crucial.Common nursing and conventional therapy often cause carbohydrate to pile up in enteric cavity to cause osmotic diarrhea to make protracted inflammation because of alactasia.Stop breast milk and lactase-containing comestibles to take in, using lactose-free baby formula powder instead is most simple effective method.Take that short-term lactose-free milk powder is auxiliary controls Acute Infantile Diarrhea, the course of disease can be made obviously to shorten.Infant easily recover normal diet and the state of an illness without repeatedly, tracing study infant grows better.Illustrate that lactose-free milk powder treatment Acute Infantile Diarrhea clinic is applied.
At present, there is number of ways to reduce the lactose content in milk, be mainly fermentation method, Hydrolyze method.Because Hydrolyze method hydrolyzes lactose is galactolipin and glucose, glucose can improve the osmotic pressure of product, increases the weight of diarrhoea; The product of fermentation method not suitable for baby is drunk, so the cow's milk protein of removing lactose can only be adopted to add vegetable oil, corn syrup, the various nutrients such as appropriate forced for vitamins, mineral matter are made.External lactose-free baby formula powder major part adopts dry mixing process, be difficult to ensure the even of the various nutrient mixing in formula, and domestic manufacturer's many employings wet processing, in wet blending process, there is Multi-channel filtering operation, greatly reduce the possibility that the impurity degree of milk powder and foreign matter enter.This complex process, equipment investment and production cost more much higher than dry mixing process, but it is even to ensure that various nutrient mixes better, but domestic manufacturer for the research of lactose-free baby formula powder also in the starting stage, manufacturer is very few, so domestic lactose-free baby formula powder market is always occupied by external famous brand.
Summary of the invention
To the object of the invention is to cow's milk protein isolate, for primary raw material, make lactose-free milk powder substitute products, as the food of lactose intolerance, diarrhoea and diarrhoea convalescence special infant, simultaneously for market provides a kind of supplementary infant formula Model of Nutrition.
Technical scheme of the present invention is achieved in that this newborn base lactose-free baby formula powder, it is characterized in that what it was made up of the raw material of following weight ratio: casoid flour 45-50, PURE WHEY 95-100; corn syrup 700-750, palm oil 90-98, soybean oil 5-70; high oleic sunflower oil 55-60; coconut oil 40-50, Choline Chloride 0.7, vitamin 1.76791; mineral matter 41.5325; nucleotides 0.42, VBT tartrate 0.12, taurine 0.4.
Described newborn base lactose-free baby formula powder nucleotide is made up of the raw material of following weight ratio: CMP172, AMP56, GMP80, UMP104, and IMP8.
In described newborn base lactose-free baby formula powder, vitamin is made up of the raw material of following weight ratio: vitamin A 80, Vitamin D5 0, vitamin E powder 300, vitamin K1 powder 10, vitamin B1 8, vitamin B2 10, vitamin B6 4, vitamin B12 0.025, vitamin C 1220, folic acid 0.7, biotin 0.185, niacinamide 50, calcium pantothenate 35.
Described newborn base lactose-free baby formula powder mineral is made up of the raw material of following weight ratio: calcium monohydrogen phosphate 16520, copper sulphate 15, zinc lactate 240, ferrous sulfate 260, magnesium sulfate 4580, Potassiumiodate 2.5, potassium chloride 8500, calcium carbonate 5000, sodium selenite 10, manganese sulfate 5, natrium citricum 6400.
Dry matter content 75% in corn syrup in described newborn base lactose-free baby formula powder, is specifically made up of the sugar of following weight ratio: glucose 1.0%-2.0%, maltose 20%-30%, maltotriose 10%-20%, all the other are for more than tetrose.
The production method of described newborn base lactose-free baby formula powder, comprises the steps:
A, PURE WHEY and casoid flour be dissolved in purify waste water in fully stir, then add corn syrup, mix;
B, with purifying waste water, vitamin, mineral matter and other nutriments are dissolved respectively after, join in the feed liquid of step gained, stir;
C, palm oil, coconut oil are preheating to 45-60 DEG C, add corn oil, soybean oil, high oleic sunflower oil, be uniformly mixed, 15MPa ~ 18MPa homogeneous, join in the feed liquid of step gained;
D, 86 DEG C ~ 89 DEG C sterilizations 15 seconds, be concentrated into 15 ° of B é;
E, intake air temperature 150 DEG C ~ 160 DEG C, air outlet temperature 84 DEG C ~ 85 DEG C spraying dry, cooling, packaging, obtain finished product.
Technological progress effect of the present invention shows:
1, take albumen powder as primary raw material, and add other auxiliaries and form, change the method for traditional lactase hydrolysis; Technique is simple, constant product quality: adopt the method for allotment to produce the insulation enzymolysis process avoiding the long period, simplify production technology, it also avoid the waste of some equipment, greatly save the production time.It also avoid the problem that the serious and local flavor of brown stain that enzyme hydrolysis method product easily occurs changes simultaneously, ensure that stablizing of product quality.
The present invention with the addition of the coconut oil containing medium chain fatty acid especially, baby is owing to growing rapidly, poor on the holding capacity of nutrition impact, sufficient energy and aliphatic acid should be supplied to ensure normal growth, LCFA need rely on VBT and enter mitochondria intracellular metabolite as carrier, and oxidative metabolism speed is slow; And medium chain fatty acid does not need to rely on VBT and can enter mitochondria and carry out Quick Oxidation, and not easily accumulate at liver.This product adopts the allotment of soybean oil, corn oil, coconut oil, palm oil, high oleic sunflower oil 5 vegetable oil to form, aliphatic acid is formed closer to breast milk, namely essential fatty acid is provided, further providing can quick energy-producing medium chain fatty acid, ensure that growing of lactose intolerance baby.
Detailed description of the invention
Below in conjunction with embodiment, the specific embodiment of the present invention is described,
(1) newborn base lactose-free baby formula powder formula for a product:
Subordinate list 1: the nucleotides by weight ratio that newborn base lactose-free baby formula powder uses
Subordinate list 2: newborn base lactose-free baby formula powder uses vitamin, mineral matter part by weight
(2) production method:
A, PURE WHEY and casoid flour be dissolved in purify waste water in fully stir, then add corn syrup, mix;
B, with purifying waste water, vitamin, mineral matter and other nutriments are dissolved respectively after, join in the feed liquid of step gained, stir;
C, palm oil, coconut oil are preheating to 45-60 DEG C, add corn oil, soybean oil, high oleic sunflower oil, be uniformly mixed, 15MPa ~ 18MPa homogeneous, join in the feed liquid of step gained;
D, 86 DEG C ~ 89 DEG C sterilizations 15 seconds, be concentrated into 15 ° of B é;
E, intake air temperature 150 DEG C ~ 160 DEG C, air outlet temperature 84 DEG C ~ 85 DEG C spraying dry, cooling, packaging, obtain finished product.
Claims (5)
1. newborn base lactose-free baby formula powder, is characterized in that what it was made up of the raw material of following weight ratio: casoid flour 45-50, PURE WHEY 95-100; corn syrup 700-750, palm oil 90-98, soybean oil 65-70; high oleic sunflower oil 55-60, coconut oil 40-50, Choline Chloride 0.7; vitamin 1.76791; mineral matter 41.5325, nucleotides 0.42, VBT tartrate 0.12; taurine 0.4
Prepared by following step:
A, PURE WHEY and casoid flour be dissolved in purify waste water in fully stir, then add corn syrup, mix;
B, with purifying waste water, vitamin, mineral matter and other nutriments are dissolved respectively after, join in the feed liquid of step gained, stir;
C, palm oil, coconut oil are preheating to 45-60 DEG C, add soybean oil, high oleic sunflower oil, be uniformly mixed, 15MPa ~ 18MPa homogeneous, join in the feed liquid of step gained;
D, 86 DEG C ~ 89 DEG C sterilizations 15 seconds, be concentrated into 15 ° of B é;
E, intake air temperature 150 DEG C ~ 160 DEG C, air outlet temperature 84 DEG C ~ 85 DEG C spraying dry, cooling, packaging, obtain finished product.
2. newborn base lactose-free baby formula powder according to claim 1, is characterized in that what described nucleotides was made up of the raw material of following weight ratio: CMP172, AMP56, GMP80, UMP104, and IMP8.
3. newborn base lactose-free baby formula powder according to claim 1, is characterized in that what described vitamin was made up of the raw material of following weight ratio: vitamin A 80, Vitamin D5 0, vitamin E powder 300, vitamin K1 powder 10, vitamin B1 8, vitamin B2 10, vitamin B6 4, vitamin B12 0.025, vitamin C 1220, folic acid 0.7, biotin 0.185, niacinamide 50, calcium pantothenate 35.
4. newborn base lactose-free baby formula powder according to claim 1, it is characterized in that what described mineral matter was made up of the raw material of following weight ratio: calcium monohydrogen phosphate 16520, copper sulphate 15, zinc lactate 240, ferrous sulfate 260, magnesium sulfate 4580, Potassiumiodate 2.5, potassium chloride 8500, calcium carbonate 5000, sodium selenite 10, manganese sulfate 5, natrium citricum 6400.
5. newborn base lactose-free baby formula powder according to claim 1, it is characterized in that in described corn syrup, dry matter content is 75%, is specifically made up of the sugar of following weight ratio: glucose 1.0%-2.0%, maltose 20%-30%, maltotriose 10%-20%, all the other are for more than tetrose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310547120.9A CN103598353B (en) | 2013-11-07 | 2013-11-07 | Breast base lactose-free baby formula powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310547120.9A CN103598353B (en) | 2013-11-07 | 2013-11-07 | Breast base lactose-free baby formula powder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103598353A CN103598353A (en) | 2014-02-26 |
| CN103598353B true CN103598353B (en) | 2015-11-18 |
Family
ID=50116667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310547120.9A Active CN103598353B (en) | 2013-11-07 | 2013-11-07 | Breast base lactose-free baby formula powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103598353B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104430898A (en) * | 2014-12-24 | 2015-03-25 | 上海优幼母婴用品有限公司 | Milk powder with immune formula |
| CN104489096B (en) * | 2014-12-24 | 2017-10-24 | 光明乳业股份有限公司 | A kind of high protein agalasisa sugar-milk and preparation method thereof |
| CN105831253A (en) * | 2016-03-23 | 2016-08-10 | 无锡超科食品科技有限公司 | Lactose-free infant formula milk powder and preparation method thereof |
| CN107874245A (en) * | 2017-11-28 | 2018-04-06 | 新干县顾品佳营养食品有限公司 | Lactose intolerance can be avoided and the nutrient powder of nutrition is provided for lactose intolerance crowd |
| EP3761796A4 (en) * | 2018-03-05 | 2021-11-17 | Agritechnology Pty Ltd | LACTOSE-FREE DAIRY PRODUCTS |
| CN114190543B (en) * | 2021-12-20 | 2023-05-26 | 青岛圣桐营养食品有限公司 | Lactose-free formula food for infants with low osmotic pressure and special medical application |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1358067A (en) * | 1999-04-29 | 2002-07-10 | 雀巢制品公司 | Composition for infant formula with low threonine content |
| CN1465261A (en) * | 2002-11-13 | 2004-01-07 | 上海光明乳业股份有限公司 | Immune formula milk powder and preparation process thereof |
| CN101803743A (en) * | 2010-02-11 | 2010-08-18 | 圣元营养食品有限公司 | Baby food composition |
| CN101904362A (en) * | 2010-08-10 | 2010-12-08 | 河北三元食品有限公司 | Soy-based infant powder and preparation method thereof |
| CN102511557A (en) * | 2011-12-29 | 2012-06-27 | 内蒙古伊利实业集团股份有限公司 | Liquid infant milk for newborn to six-month-old infant and production method thereof |
-
2013
- 2013-11-07 CN CN201310547120.9A patent/CN103598353B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1358067A (en) * | 1999-04-29 | 2002-07-10 | 雀巢制品公司 | Composition for infant formula with low threonine content |
| CN1465261A (en) * | 2002-11-13 | 2004-01-07 | 上海光明乳业股份有限公司 | Immune formula milk powder and preparation process thereof |
| CN101803743A (en) * | 2010-02-11 | 2010-08-18 | 圣元营养食品有限公司 | Baby food composition |
| CN101904362A (en) * | 2010-08-10 | 2010-12-08 | 河北三元食品有限公司 | Soy-based infant powder and preparation method thereof |
| CN102511557A (en) * | 2011-12-29 | 2012-06-27 | 内蒙古伊利实业集团股份有限公司 | Liquid infant milk for newborn to six-month-old infant and production method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103598353A (en) | 2014-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103598353B (en) | Breast base lactose-free baby formula powder | |
| CN101984836B (en) | Method for producing novel infant formula milk powder | |
| CN101123888A (en) | Oligosaccharide mixture | |
| CN103478547B (en) | Infant nutrition rice flour containing cymbopogon citrates aqueous extract and preparation method thereof | |
| CN103070241A (en) | Infant-formula goat milk powder of pure goat milk protein and preparation method thereof | |
| CN103583692A (en) | Symbiotic functional high-protein Greek yogurt utilizing polymeric whey protein as main thickening agent and preparation method thereof | |
| CN103947752A (en) | Kiwi fruit enzyme yogurt and preparation method thereof | |
| CN110122865B (en) | Infant auxiliary food added with breast milk oligosaccharide and preparation method thereof | |
| CN112075504A (en) | Infant formula milk powder for enhancing immunity | |
| CN106235215B (en) | Lily jelly and processing technology thereof | |
| CN104082413A (en) | A kind of preparation method of sugar-free purple sweet potato yoghurt | |
| CN105285993A (en) | Passion fruit enzyme powder and preparation method thereof | |
| CN104720051A (en) | Method for preparing seaweed beverage employing eucheuma extracting solution | |
| CN105831253A (en) | Lactose-free infant formula milk powder and preparation method thereof | |
| CN103222604B (en) | Method for producing daylily pickle through mixing fermentation of multiple bacterial | |
| CN101904362B (en) | Soy-based infant powder and preparation method thereof | |
| CN102613292A (en) | Health-care sour milk for elderly people and production method thereof | |
| CN101803743B (en) | Baby food composition | |
| CN106212723A (en) | A kind of babies ' formula milk powder and preparation method thereof | |
| CN103271166A (en) | Soybean whey composite powder and preparation method thereof | |
| CN102524420A (en) | Dry process for the production of immune system milk powder | |
| CN101928667B (en) | Starter for and preparation method of yogurt enriched with zinc | |
| CN102047963A (en) | Preparation method of sweet potato yoghourt | |
| CN101313706B (en) | Local flavor sour camel milk and preparation method thereof | |
| CN103494052B (en) | A kind of polypeptide infant calcium supplement instant granule and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |